Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Overweight × Cyproterone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 1 Overweight 1 Obesity 1

Interventions

sultamicillin 1 licogliflozin 1 drospirenone and ethinyl estradiol combination 1 drospirenone 1 bupropion hydrochloride, naltrexone hydrochoride drug combination 1 Sugars 1 Naltrexone 1 Metformin 1 Flutamide 1 Exenatide 1 Ethinyl Estradiol 1 Cyproterone 1 Bupropion 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03151005 2023-12-04

The Effect of GLP-1 Agonists Versus OCs on Reproductive Disorders and Cardiovascular Risks in Overweight PCOS

Xinqiao Hospital of Chongqing

Phase 4 Completed

70 enrolled 11 charts

Obesity, Polycystic Ovary Syndrome, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon ⚡